ASCO: Sanofi says early amcenestrant data could see it be 'endocrine backbone...

cafead

Administrator
Staff member
  • cafead   May 19, 2021 at 11:32: PM
via A new early peek at data from Sanofi’s breast cancer hopeful amcenestrant has encouraged the French Big Pharma to see it placed firmly at the front of future treatment pathways.

article source
 

<